• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
IONS

IONS

Ionis Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD73.82

+0.85 (+1.16%)

Rating:D+

Company Profile

CEO

Brett Monia

IPO Date

1991-05-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$72.68

Prev. Close

$72.97

Day Low

$72.02

Day High

$74.12

52W Low

$34.78

52W High

$86.74

Market Cap

$12.20B

Volume

1.27M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

28.3%

Avg Negative

20.6%

Avg Neutral

51.1%

News Feed

Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen

PRNewsWire·7/29/2021·↑ positive

Ionis to hold second quarter 2021 financial results webcast

PRNewsWire·7/21/2021·↑ positive

Ionis (IONS) Inks Deal With Bicycle Therapeutics for LICA Drugs

Zacks Investment Research·7/14/2021·↑ positive

Bicycle, Ionis To Develop Targeted Oligonucleotide Therapeutics

Benzinga·7/13/2021·↑ positive

Ionis Pharmaceuticals Stock Looks Attractive At $37

Forbes·6/23/2021·↓ negative

Ionis' Chief Scientific Officer C. Frank Bennett, Ph.D.

PRNewsWire·6/14/2021·↓ negative

Ionis' antisense therapies in ATTR amyloidosis to be featured at 2021 PNS Annual Meeting

PRNewsWire·6/10/2021·↑ positive

Why Is Ionis Pharmaceuticals (IONS) Down 7% Since Last Earnings Report?

Zacks Investment Research·6/4/2021·↓ negative

Ionis announces changes to its board of directors at annual meeting of stockholders

PRNewsWire·6/2/2021·↓ negative

Ionis: Price Slump Is An Opportunity To Buy The Pipeline

Seeking Alpha·6/2/2021·↓ negative